Usana Health Sciences, Inc. (USNA) Tops Q1 EPS by 21c; Boosts FY12 Revs Outlook
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Join SI Premium – FREE
Usana Health Sciences, Inc. (NYSE: USNA) reported Q1 EPS of $0.90, $0.21 better than the analyst estimate of $0.69. Revenue for the quarter came in at $154.1 million versus the consensus estimate of $145.33 million.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.60-$3.70, versus the consensus of $3.44. Usana Health Sciences, Inc. sees FY2012 revenue of $610-$625 million, versus prior guidance of $600-$615 million and the consensus of $611 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.60-$3.70, versus the consensus of $3.44. Usana Health Sciences, Inc. sees FY2012 revenue of $610-$625 million, versus prior guidance of $600-$615 million and the consensus of $611 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Riskified Ltd. (RSKD) Reports In-Line Q2 EPS ; Offers Guidance
- Nebius soars on second quarter revenue beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
